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Abstract 
THE INCIDENCE OF POSTOPE R AT I VE RETCH ING A ND VOMITING IN THE ADULT 
PAT IENT UNDERGO ING ABDOM INAL SU RGE RY FOLLOWING INTRAOPE RAT IVE 
ADM I NISTR ATION OF D ROPE R IDOL 
Gary L. Miller, B.S. N. 
The com plication of postoperative nausea and vomiting is still one 
of the most common today. The potential for secondary complications 
associated with retching and vomiting such as aspiration pneumonitis 
strain of suture line with possible hemorrhage, and potential fluid and 
electrolyte imbalance makes prevention of retching and vomiting a 
primary concern in the management of the postoperative patient. 
The use of antiemetic drugs to prevent or control postoperative 
nausea and vomiting is a long-standing practice. Droperidol, an 
antiemetic, routinely used since being introduced in 1963, has been 
found to be successful in treating postoperative nausea and vomiting. 
This study examines the effect of droperidol .018 mg/kg given 
intramuscularly one half hour prior to the end of anesthesia on 
postoperative emesis in the adult gynecological patient presenting for 
total abdominal hysterectomy. 
Twelve patients were in this double-blind study, six acted as 
controls and six were in the experimental group. All subjects were 
premedicated with morphine sulfate 0 .1 mg/kg and glycopycolate 0.2 mg, 
intramuscularly administered. All were induced with pentathol 4 mg/kg 
preceded by curare 3 mg and followed by succinylcholine 1 .5 mg/kg for 
intubation. The subjects were maintained on isoflurane, sixty percent 
nitrous in oxygen, and pancuronium for relaxation. The subjects were 
of similar age and weight. Duration of anesthesia was similar with a 
mean of 2.93 hours overall. 
The incidence of retching or vomiting was considered as the same 
result. The droperidol group had one subject retch only and another 
retch and vomit. This gave a 33 percent incidence of retching and 
vomiting. T he control group had three subjects retch and vomit, giving 
a 50 percent incidence. The small sample size provided no statistical 
significance. 
The results showed a trend of decreased vomiting in the adult 
subject presenting for total abdominal hysterectomy. The routine use 
of droperidol in this particular population cannot be recommended from 
these results. 
CHAPTER 1 
Introduction 
Problem Statement 
The complication of postoperative nausea and vomiting is still one 
of the most common today ( 1,2,3). Patients often reveal that fear of 
postoperative nausea and vomiting is one of their primary concerns. A 
prior experience with postoperative nausea and vomiting may increase 
that patient's stress level and make it much more difficult to 
emotionally prepare that patient for surgery. The potential for 
secondary complications associated with retching and vomiting such as 
aspiration pneumonitis, strain of suture line with possible hemorrhage, 
cerebral accident due to increased intracranial pressure, potential 
fluid and electrolyte imbalance, and possible trauma to the esophagus, 
makes prevention of retching and vomiting a primary concern in the 
management of the postoperative patient. 
The use of antiemetic drugs to prevent or control postoperative 
nausea and vomiting is a long standing-practice dating back to the 
1950's. Droperidol, an antiemetic, routinely used since being 
introduced in 1963 has been found to be successful in treating 
postoperative nausea and vomiting (2,4,5,6,7,8). Droperidol acts by 
blocking the dopaminergic receptors in the Chemoreceptor Trigger Zone 
(CTZ). This inhibits the transmission of emetic stimuli from the CTZ 
to the Emesis Center (EC). The EC actually stimulates vomiting. The 
effectiveness of Droperidol has been often studied but very little 
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research is based on a milligram per kilogram basis. 
The purpose of this study is to arrive at the effectiveness of 
Droperidol in preventing postoperative retching and vomiting based on a 
specific milligram per kilogram basis. 
Research Question 
What is the effect of intramuscular droperidol given 
intraoperatively 30 minutes prior to the end of anesthesia on the 
incidence of postoperative retching and vomiting in the adult patient 
undergoing intra-abdominal surgery without bowel resection, for 24 
hours postop? 
Definition of Terms 
1. Retching: The active attempt of the patient to expel stomach 
contents without success. 
2. Vomiting: The active effort of the patient to expel stomach 
contents with success. 
3. Droperidol (Inapsine): A butyrophenone tranquilizer with 
alpha adrenergic and dopaminergic antagonistic 
qualities causing moderate hypotension, sedation, 
and antiemetic effects. 
4. Adult patient: A non-obese, ASA I or II female, 18-49 years 
of age undergoing an intra-abdominal surgical 
procedure without bowel resection . 
5. ASA: American Society of Anesthesiologists. A categorizing 
of patient's physical condition. 
A) Class I: "The patient has no organic, physiologic, 
biochemical, or psychiatric disturbance. The 
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pathologic process for which the operation is to be 
performed is localized and does not entail a 
systemic disturbance ." 
B) Class II: "Mild to moderate systemic disturbance 
caused either by the condition to be treated 
surgically or by other pathophysiologic processes. " 
6. End of Anesthesia: Removal of the endotracheal tube. 
7. Intramuscular: Left deltoid injection. 
B. Non-obese: Less than 20 percent above ideal body weight . 
Hypothesis 
The adult patient will experience no reduction in the incidence 
of postoperative retching and/or vomiting after receiving droperidol 
.01B mg/kg 1M intra-operatively . 
Variables 
Dependent: Postoperative retching and vomiting. 
Independent: Intramuscular administration of droperidol .01B mg/kg 
administered intra-operatively. 
Assumptions 
1. The nursing staff will record all incidents of retching and 
vomiting postoperatively. 
2. The patient will accurately report all incidents of retching 
and vomiting not recorded by the nursing staff. 
Limitations 
1. The investigator will rely on the nursing staff to accurately 
record all incidents of retching and vomiting. 
2. The investigator will rely on the skill of the anesthetist to 
ventilate the patient without pushing air into the stomach. 
Delimitations 
1. The patient will be assigned to one of two groups, a control 
or an experimental group, based on a random table of numbers in a 
double-blind fashion. 
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2. In an effort to control the variables of postoperative 
retching and vomiting within this study, a homogeneous group consisting 
of females, ages 18-49 years, ASA I or I I, non-obese, undergoing an 
intra-abdominal surgical procedure lasting two to four hours without 
bowel resection were utilized . 
Theoretical Framework 
Nausea, Vomiting, and Associated Factors 
Vomiting is described as the active expulsion of gastric contents 
through the mouth. This is immediately preceded by tachypnea, 
salivation, and pupil dilation resulting from an autonomic discharge. 
There are two areas of the brain responsible for vomiting, the emesis 
center (EC ) and the chemoreceptor trigger zone ( CTZ ). These two centers 
are located in the medulla and when sufficiently stimulated, vomiting 
occurs (9,10). 
The EC is located near the dorsolateral border of the lateral 
reticular formation and ventral to the tractus solitarious and its 
nucleus. This area of the medulla also contains the respiratory 
center, salivatory nuclei, vasomotor center, vestibular nuclei, and 
bulbofacilitatory and inhibitory systems . The EC is located in the 
center of these regulatory nuclei which explains the patterned 
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response, earlier described, during vomiting ( 10). The EC may be 
directly stimulated by efferent pathways from various locations. For 
example, mucosal irritation of the gastrointestinal tract, mechanical 
distention of bowel or biliary tract, myocardial infarction, meniere's 
disease, vestibular neuronitis, or viral hepatitis may stimulate the EC . 
The EC may also be indirectly stimulated via the CTZ (3). 
The CTZ is located in the medulla superficial to the EC area 
postrema in the floor of the fourth ventricle. The CTZ can be 
stimulated by drugs such as digitalis, antibiotics, cytotoxic agents, 
alcohol, ergots, opiates, and inhalation anesthetics. Also, the CTZ 
may be stimulated by toxicosis such as diabetic acidosis, uremia, and 
carcinomatosis, or stimulated by radiation and motion sickness (3,1 1). 
There are numerous factors that correlate with the incidence of 
vomiting when considering the postoperative patient, i .e., sex, age, 
weight, preoperative medication, anesthetic technique, operative site, 
duration, postoperative pain, and gonadotropin levels (9,12, 13, 14) 
Studies have shown that female patients experience an increased 
incidence of vomiting as compared to male patients (9) . Janhunen and 
Tammisto reported an 18. 1 percent difference in the incidence of 
postoperative vomiting between male and female patients ( 15). A 
difference of 15.8 percent was reported by Iwamoto and Schwartz (4). 
The difference in the incidence of postoperative vomiting between the 
sexes is also interrelated to the age of the patient. 
Various age groups of adult patients experienced a difference in 
the incidence of postoperative vomiting (6, 12, 14,16) Females 40-49 
years of age and males 60-69 years of age experienced the highest 
incidence of postoperative vomiting compared to other age groups from 
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20-29 through 60-69 years of age ( 15). 
The obese patient, either male or female, experiences a higher 
incidence of postoperative nausea and vomiting (6, 7, 12, 14). Bellville 
postulated that obese patients have a large fat reservoir to absorb the 
anesthetics as well as other drugs which chemically stimulate nausea 
and vomiting (9). 
The pre-operative medication also plays a role in the incidence of 
postoperative nausea and vomiting (7). It is generally known that 
narcotics are associated with an increased incidence of vomiting 
postoperatively when used as a premedicant. Morphine, with a 42 
percent incidence of postoperative nausea and vomiting, has been the 
most extensively studied, but meperidine has also been implicated in 
postoperative nausea and vomiting ( 14). Bellville found a biphasic 
dose relationship curve when comparing incidence of postoperative 
nausea and vomiting to the dose of meperidine administered . The 
incidence of nausea and vomiting was higher at doses lower than and 
higher than one milligram/kilogram (9). 
The anesthetic technique has long been implicated in the incidence 
of postoperative nausea and vomiting. Bonica et al. ( 12) implicated 
ether to have an incidence of 64.2 percent nausea and vomiting. 
However, Bellville equated this high percentage with anesthetic depth 
when ether was used for muscle relaxation and was obtained by deep 
levels of anesthesia ( 17). Bellville found the incidence of 
postoperative nausea and vomiting with cyclopropane to be 26 
percent (9). Halothane was later studied and found to have a low 
incidence of postoperative nausea and vomiting of 19. 5 percent ( 13). 
Ethrane was studied for its contribution to postoperative nausea and 
vomiting by Iwamoto and Schwartz (4). Results of 42. 1 percent 
incidence of nausea and vomiting were obtained. In another study, 
nitrous oXide/oxygen/fentanyl anesthetic technique was compared to 
isoflurane/fentanyl/oxygen and isoflurane/oxygen technique. Of the 
patients from each group that experienced nausea and vomiting, 
6 1  percent received 70 percent nitrous oxide/oxygen/fentanyl, 
30 percent received 1- 1.5 MAC isoflurane/oxygen/fentanyl, and 
25 percent received 1-1.5 MAC isoflurane/oxygen ( 1). Besides the 
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agent used, the skill of the anesthetist must be considered as part of 
the anesthetic technique. Improper ventilation can lead to air trapped 
in the stomach, elevation of P C02, decreased P02, and hypotension, 
all of which can lead to increased risk of vomiting (9, 17). 
The operative site has been implicated in contributing to the 
incidence of postoperative vomiting and retching. Intra-abdominal 
procedures resulted in a higher incidence compared to other operative 
sites (2, 9, 14, 15, 17). Mortensen et al. reported 61. 1  percent and 
Bonica reported 44 .2 percent incidence of postoperative nausea 
and vomiting following intra-abdominal procedures (6, 12). 
The duration of anesthesia has been correlated with an increased 
incidence of postoperative nausea and vomiting (2,4,7, 14). However, 
most studies used short cases lasting less than 15 minutes to 2 hours. 
Bellville studied a greater range divided into one hour blocks and found 
a significant difference ( 17). He found only 17.5 percent incidence 
with cases 1/2 hour to 1 1/2 hours, 28.4 percent with 1 1/2 hours to 
2 1/2 hours, and 46 percent incidence with 2 1/2 to 3 1/2 hours . 
Postoperative pain and its treatment play a role in the incidence 
of postoperative nausea and vomiting. Bellville (9) found that 41 
percent of those that had emesis experienced pain . While it is 
difficult to evaluate postoperative analgesics for pain and their 
significance towards nausea and vomiting, narcotics have already been 
implicated concerning nausea and vomiting, and one can assume a 
contri bution from them. Attempts to determine a significance proved 
unsuccessful (15). 
The level of gonadotropin associated with the third and fourth 
week of the menstrual cycle has been implicated in an increased 
incidence of postoperative nausea and vomiting (9,14,15) . Bellville 
goes on to say that there is a definitive correlation between the 
greatest incidence of nausea and vomiting, and the gonadotropin levels 
peaking between the sixth through the twelfth week of pregnancy. 
However, no difference in postoperative nausea and vomiting exist 
between premenopausal and postmenopausal women (17). 
Droperidol 
Droperidol is a butyrophenone tranquilizer and neuroleptic agent. 
It was first synthesized in Belgium by Janssen. In the original 
studies, Janssen discovered that droperidol had a potent antiemetic 
effect (18). 
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While droperidol's original anesthetic use as a premedicant, 
induction agent, or use with fentanyl as a neuroleptanesthetic 
continued, more studies appeared a bout it's superior antiemetic effects 
(2,3,4, 5,6, 7, 8). This effect is caused by droperidol blocking 
dopaminergic receptors in the chemoreceptor trigger zone (CTZ). This 
antagonist activity inhibits the transmission of emetic stimuli from 
the CTZ to the emesis center (EC) (19,20,21). Loeser et al. suggests 
that droperidol may also have a direct effect on the EC itself (5). 
Droperidol has also demonstrated alpha blocking ability resulting in 
moderate decrease in blood pressure after administration of moderate 
doses of 5 mg or greater in adults (20,22). 
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Droperidol was found to be effective as an antiemetic 30 minutes 
after intramuscular administration and last up to 24 hours with its 
peak effect 6 to 12 hours post administration (2). 
The metabolism of droperidol is very rapid. The elimination 
half-life in human subjects was uniformly 134 minutes, suggesting a 
similar response between patients. The metabolites are inactive and 
make up 86 percent of the excreted product. Urinary excretion makes 
up 75 percent of the products (19). After 24 hours, 83 percent of the 
drug had been excreted (21). 
Conclusion 
Nursing goals of caring for the postoperative patient suffering 
from nausea and vomiting are to maintain proper hygiene, maintain fluid 
and electrolyte ba�ance, achieve rest, prevent physical injury, achieve 
comfort, and prevent psychological alteration. 
The physician's goal is to stop emesis by prescribing the 
antiemetic that is currently the most effective drug available. 
The interrelationship that the medical discipline and the nursing 
diSCipline have is a co-existing responsibility to therapeutically 
intervene and correct the postoperative complication. 
CHAPTER 2 
Literature Review 
In the 1950's Borison and Wang contributed immensely to our 
understanding of the mechanism of nausea and vomiting. Through 
research with cats using implanted electrodes they were able to locate 
two separate areas in the medulla responsible for vomiting (23). The 
incidence of postoperative nausea and vomiting was quite high at this 
time and was generally attributed to ether, the primary anesthetic of 
that time ( 12). Research of preventing postoperative nausea and 
vomiting was primarily focused on antihistamines and anticholinergics. 
The list of variables associated with postoperative nausea and vomiting 
was growing. Bellville et al. published an article outlining a 
research format to control these variables and to accurately compare 
the many antiemetics entering the market (24). Variations on this 
format are still used today for research of antiemetics. 
In the early 1960's, phenothiazines were considered the drug of 
choice for postoperative nausea and vomiting (9). Then Janssen et al 
( 18) introduced a butyrophenone called droperidol with potent 
antiemetic effects. Research was also continuing to define the anatomy 
involved in the process of vomiting ( 10). By 1969, halothane was well 
established as an anesthetic and studies revealed it to have a reduced 
incidence of postoperative nausea and vomiting when compared to ether 
and cyclopropane. Gold reported a 14.3 percent incidence of 
postoperative nausea and vomiting associated with halothane ( 13). That 
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same study resulted in 5 1. 8  percent with ether and 43.6 percent with 
cycloprane. Gold's study utilized 1223 women undergoing gynecological 
surgery. 
1 1  
By 1970, the list o f  variables associated with postoperative 
nausea and vomiting was nearly complete. McKie reviewed the literature 
and published the following list: anesthetic agents and technique, 
premedicant drugs, operative site, age and sex, duration of operation, 
hypoxia, hypercarbia and hypotension, rough handling of the patient, 
experience of the anesthetist, physical status, use of nasogastric 
tube, position, emotional factors, and postoperative pain ( 14). 
Janhunen and Tammisto further supported McKie's findings ( 15). Later 
Cressman et al. and Soudijn et al., in separate studies, contributed to 
the understanding of the absorption, metabolism, excretion, and 
mechanism of action of droperidol in human subjects ( 19,2 1). This 
lead to an increase in the studies of droperidol as an antiemetic agent. 
Patton et al. compared it in a double blind study using droperidol and a 
placebo (7). Hi� study, utilized 41  patients undergoing hysterectomy 
with ether anesthesia and revealed a 56 percent difference in the 
incidence of postoperative nausea and vomiting during the first six 
hours. Winning et al. compared droperidol to diphenido1 and a placebo 
in 2 1  patients and found that droperidol resulted in a 14 percent 
difference in the incidence of postoperative nausea and vomiting 
compared to diphenidol and a 22 percent difference compared to the 
placebo (8). Iwamoto and Schwartz studied the effects of droperidol on 
78 ophthalmic surgery patients using enflurane as the anesthetic (4). 
The placebo group experienced an incidence of 42 percent postoperative 
nausea and vomiting. The patients who received droperidol experienced 
12 
an incidence of 16 percent postoperative nausea and vomiting. 
Korttila et al. compared domperidone, droperidol, and metaclopramide in 
the prevention and treatment of nausea and vomiting following balanced 
general anesthesia (2). Korttila used a lower dose of droperidol than 
usually studied, 1. 25 milligrams. Once again, droperidol provided the 
lowest incidence, 17 percent, of postoperative nausea and vomiting 
compared to the placebo, 40 percent; metaclopramide and domperidone, 35 
and 40 percent, respectively in the 185 females undergoing orthopedic 
surgery. A similar comparison of droperidol, haloperidol and 
prochlorperazine proved that droperidol was the superior antiemetic (5). 
Droperidol has also been studied for characteristics other than 
antiemetic effects. For example, Soroker et al. compared diazepam and 
droperidol for their effects on respiratory function. Diazepam 
10 milligrams didn't effect respiratory function, but droperidol 
5 milligrams reduced the tidal volume in all 14 normal subjects. 
However, the reduction of 13.3 percent was not enough to alter blood 
gas tensions (25). 
The 1980's have brought more research on the variables implicated 
in postoperative nausea and vomiting and more research on the potent 
antiemetic, droperidol. Perreault et al. studied variations in middle 
ear pressure during nitrous oxide administration and found, in patients 
with blocked eustachian tubes, that negative pressure in the immediate 
postoperative period was sufficient to cause irritation of the 
vestibular system leading to nausea and vomiting (26). Another study 
of 77 females found a 61 percent incidence of postoperative nausea and 
vomiting associated with 70 percent nitrous oxide ( 1) .  Mortensen 
studied the antiemetic effects of droperidol on 300 gynecological 
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patients using nitrous oxide 67 percent in oxygen and pancuronium. Two 
different doses were used as well as a placebo . Mortensen found 
34. 4 percent incidence postoperative nausea and vomiting in the placebo 
group and in the 2.5 and 5. 0 milligram groups, 15.2 and 10.3 percent 
were respectively recorded (6). Santos and Datta studied the effects 
of droperidol on 50 subjects undergoing elective caesarean under spinal 
anesthesia (27). Their placebo group experienced 40 percent and their 
droperidol group experienced 12 percent postoperative nausea and/or 
vomiting. Interestingly enough, the droperidol group experienced only 
nausea 12 percent and the placebo group experienced 12 percent 
vomiting. 
This study will attempt to add to the body of knowledge on the 
use of droperidol in adults. The research is similar to that of 
Mortensen (6). The research is attempting to update the efficacy of 
droperidol with today's anesthetics. To date, no published research 
exists utilizing isoflurane, quickly becoming the standard inhalation 
anesthetic, and the concomitant use of droperidol as an antiemetic. 
CHAPTER 3 
Methodology 
Research Design 
This investigator conformed to a quasi-experimental design. There 
were two groups that patients were randomly assigned to. Patients in 
group I received droperidol .018 mg/kg intramuscularly 30 minutes prior 
to the end of anesthesia. Group II received no antiemetic treatment 
intra-operatively. 
The subjects were a sample of convenience and were assigned to a 
group based on random sampling from a table of random numbers. Patient 
numbers were assigned on the basis of the sequence that patients 
consented to the study . The selection of group assignment was double 
blind. 
Population, Sample, Setting 
The population of this study consisted of the patients assigned to 
the gynecological surgery service of a 1, 000 bed teaching hospital 
located in the southeast United States. A sample of convenience was 
drawn from this population which met the criteria of this study. The 
subjects were female, 18-49 years of age, ASA class I or I I, nonobese, 
and scheduled for intra-abdominal gynecological surgery under 
endotracheal general anesthesia. 
Protocol 
The protocol and consent forms were approved by the Committee on 
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the Conduct of Human Research. The protocol was discussed with the 
patient the night before surgery and informed consent was obtained. 
Group I and I I  patients were premedicated with morphine sulfate 
.1 mg/kg and glycopycolate .2 mg intramuscularly. All premedications 
were given on call to the operating room. 
A standard induction was used on both groups consisting of D-tubo 
curare 3 milligrams, pre oxygenate with 100 percent oxygen for 5 
minutes, pentathol 50 milligrams test dose followed by 4 mg/kg, 
Succinylcholine 1 .5 mg/kg, laryngoscopy and endotracheal intubation. 
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Maintenance anesthesia was by isoflurane, nitrous oxide 60 percent 
in oxygen, and muscle relaxation by pancuronium .04 mg/kg as needed. 
Appropriate intravenous fluid administration and monitoring were 
conducted. 
Subjects were eliminated from the study if the pre-operative 
medication was inadequate and the patient appeared emotionally 
distraught. Also, patients were eliminated if the induction resulted 
in air in the stomach, hypoxia, hypercarbia, or hypotension greater 
than 30 percent of baseline. Furthermore, a range of two to four hours 
for the entire procedure was established to make the duration 
consistent. 
Approximately 30 minutes before completion of anesthesia, group I 
received droperidol . 018 mg/kg intramuscularly in the left deltoid 
muscle. Group I I  received one half milliliter normal saline at that 
same time in the same fashion. 
Data collection of retching and vomiting over the next 24 hours 
was accomplished by review of the anesthesia record, recovery room 
record, and the floor nursing record. The patient was also questioned 
as to the incidence of and frequency of retching and/or vomiting. 
Nausea was not looked at by the investigator to eliminate the 
subjective nature of collecting that data. 
16 
CHAPTER 4 
Analysis of Data 
A total of 13 subjects were in this study. One subject was 
excluded from the data analysis due to failure to meet intraoperative 
and postoperative criteria. Subject number three had a nasogastric 
tube placed intraoperatively secondary to the presence of air in the 
stomach after induction. This left a total of 12 subjects for data 
analysis. 
There were six control subjects in the study. The mean age was 38 
years (range 3 1  to 45 years), and the mean weight was 68.4 kilograms 
(range 56 to 76.4 kilograms). The mean anesthesia time was 2.88 hours 
(range 2.5 to 3.2 hours). Of the six control subjects, three 
experienced retching and vomiting postoperatively. Two out of the 
three control subjects which experienced retching and vomiting 
complained of postoperative pain and received morphine sulphate for 
analgesia in the recovery room. 
There were six subjects in the experimental group. The mean age 
was 37 years (range 28 to 46 years), and the mean weight was 54 
kilograms (range 49 to 60 kilograms). Mean anesthesia time was 2.98 
hours (range 2.7 to 3.4 hours). One out of the six experimental 
subjects experienced retching and vomiting postoperatively. Also, one 
out of six experienced only retching. The one experimental subject 
that experienced postoperative retching and vomiting complained of 
postoperative pain and received morphine sulphate for analgesia in the 
17 
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recovery room. 
All 12 subjects received identical preoperative medications and 
anesthetics . All 12 subjects underwent total abdominal hysterectomies. 
Of the six control subjects, three (50 percent) retched and/or vomited . 
The six experimental subjects had two (33 percent) retch and/or vomit. 
The small sample size of this study requiring a 2 x 2 table 
dictated that the Fisher Exact Test (one tail) be utilized for 
statistical analysis (29). The results proved to be statistically 
insignificant at the . 05 level and failed to reject the null 
hypothesis. Therefore, no difference in retching and/or vomiting 
between control and experimental exists (Table 1). Analysis of 
subjects' weight and duration of anesthesia also proved to be 
statistically insignificant based on the student's T test. However, 
the mean age of the subjects which retched and/or vomited compared to 
those who did not was significant at the .05 level. Further 
scrutinizing this data with the Fisher Exact Test demonstrated that all 
of the subjects 40 to 49 years of age experienced retching and/or 
vomiting. This age group represents four out of the five subjects that 
experienced retching and/or vomiting (Table 2). Analysis of subjects 
who received postoperative morphine sulphate for complaints of pain 
proved statistically insignificant on the .05 level . Postoperative 
drowsiness was reported more frequently in the subjects who received 
droperidol. 
Frequency 
Percent 
Row Pct 
Col Pct N 
C 
E 
Total 
Key: 
C - control 
E - experimental 
Table 1 
Difference in Retching and/or Vomiting 
in Control and Experimental 
(P<.05) 
Y Total 
3 3 6 
25.00 25.00 50.00 
50.00 50.00 
42.86 60.00 
4 2 6 
33.33 16.67 66.67 
66.67 33.33 
57.14 40.00 
7 5 12 
58.33 4 1.67 100.00 
N - no retch and/or vomit 
Y - retch and/or vomit 
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Table 2 
Difference in Retching and/or Vomiting by Age 
(P>.05) 
Frequency 
Percent 
Row Pct 
Col Pct N 
40 and Over 
Less than 40 
Total 
Key: 
Age: 40 and over 
less than 40 
0 
0 
0 
0 
7 
58.33 
87. 50 
100. 00 
7 
58.33 
N - no retch and/or vomit 
Y - retch and/or vomit 
Y Total 
4 4 
33.33 33.33 
100.00 
80. 00 
1 80 
8.33 66. 67 
12. 50 
20.00 
5 12 
4 1. 67 100. 00 
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CHAPTER 5 
Discussion 
The overall incidence of retching and/or vomiting in this study 
was 50 percent in the control group and 33 percent in the experimental 
group. While it has been noted that the sample size prevents 
statistical significance, possible trends may exist that are similar 
to previous studies (2,6,7). The age of the subject and its effect on 
postoperative retching and vomiting proved statistically significant on 
the . 05 level. This correlated with Janhunen and Tammisto which found 
females age 40-49 years had the highest incidence of vomiting ( 15). 
Most variables in this study were controlled. The sex, weight, 
age, type of operation, duration, type of anesthetic, and preoperative 
medication were all controlled. However, subjective evaluation was 
required as to the emotional status of the patient preoperatively as 
well as quality of induction by the anesthetist. The very nature of 
subjective evaluation requires comment as to possible limitations on 
this study. 
Recommendations 
The following recommendations for future research are suggested: 
1. Repeat study with an increased sample size to determine 
if results would be statistically significant. 
2. Repeat study with an increased sample utilizing only 
40-49 year age group to determine if prophylactic 
treatment would be statistically significant. 
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3 .  Repeat study with increased sample size to determine 
effect of postoperative administration of narcotics on 
patients treated with droperidol. 
Conclusion 
While the results of this study have not been statistically 
significant, a trend of decreased retching and vomiting exists in 
those su bjects who received droperidol. Therefore, droperidol can 
not be recommended as routine prophylaxis for the adult female 
presenting for total a bdominal hysterectomy. 
22 
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Appendix A 
Consent Form 
The purpose of this study is to determine the effectiveness of a 
prescribed dosage of Droperidol in preventing postoperative retching and 
vomiting. 
Nonpregnant patients, like yourself, undergoing abdominal surgery 
are at an increased risk of suffering from retching and vomiting after 
the operation. It is known that Droperidol (an anti-nausea drug) can 
reduce the occurance of retching and vomiting in the postoperative 
period. Droperidol has been used for this purpose since 1963. 
Should you decide to participate in this study you will be randomly 
assigned to one of two groups: 
Group I - Will receive a routine preoperative medication. 
Group I I  - Will receive a routine preoperative medication plus 
a routine dose of Droperidol during the operation. 
Upon arrival to the operating room a routine intravenous infusion will 
be started. Your heart beat and blood pressure will be monitored and 
anesthesia administered. 
The side of effects of Droperidol may include: mild to moderate 
hypotension (low blood pressure) and postoperative drowsiness. 
The conduct of anesthesia will be the same regardless of whether or 
not you participate in this study. If at any time during anesthesia 
your safety is compromised, the study will be discontinued. 
I agree that the information obtained from this study may be used 
for teaching or for publication in scientific literature. My name and 
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identity will be kept confidential. 
I understand that in the event of any physical and/or mental injury 
resulting from my participation in this study, Virginia Commonwealth 
University will not offer compensation or medical treatment. 
signature date 
witness 
Appendix B 
Data Collection Sheet 
Patient Data 
SubJ'ect #_____ Age 
-----
A SA_
�
______ Wt 
Procedure. 
___
__
____
__
__
__
__
______ :���_-_-_-_-_-_-_ 
Pre-op: satisfactory / unsatisfactory 
Induction Time: 
----------------------
Problems: 
__________
__
__
__________
__
__
__
__
__ 
_ 
Length of Anesthesia: __________ hours 
Recovery Room 
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Required narcotics: ______________
____
__
____
__
____
__
__
__
__
__
__
__ 
_ 
Problems: 
------------------------------------
FREQUENCY 
TIME RETCH ING VOMIT ING 
COMME NTS: 
Appendix C 
Raw Data 
Subject Experimental/ Age in Weight in Duration of Postop Pain and Retch and/or Length Time 
Number Control Years Kilograms Anesthesia Tx Morphine mg. Vomit Frequency after Anesthesia 
1 C 38 76.4 2.5 0 1 14.0 
2 C 44 76 3.2 4 3 1.05 
3 excluded 19 58 2.6 6 0 
from study 
4 C 36 56 2.8 0 0 
5 C 35 68 2.9 4 0 
6 E 34 60 3.1 0 0 
7 E 28 50 2.8 0 0 
8 E 46 49 3.1 2 1 6.65 
9 E 41 55 3.4 0 1 7.76 
10 E 38 60 2.8 0 0 
11 C 31 62 2.9 4 0 
12 E 36 50 2.7 0 0 
N 
13 C 45 72 3.0 4 1 2.75 '" 
Vita 
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